Cargando…

Structural and Functional Insights into CP2c Transcription Factor Complexes

CP2c, also known as TFCP2, α-CP2, LSF, and LBP-1c, is a prototypic member of the transcription factor (TF) CP2 subfamily involved in diverse ubiquitous and tissue/stage-specific cellular processes and in human malignancies including cancer. Despite its importance, many fundamental regulatory mechani...

Descripción completa

Detalles Bibliográficos
Autores principales: Son, Seung Han, Kim, Min Young, Jo, Eunbi, Uversky, Vladimir N., Kim, Chul Geun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223585/
https://www.ncbi.nlm.nih.gov/pubmed/35742810
http://dx.doi.org/10.3390/ijms23126369
_version_ 1784733160699854848
author Son, Seung Han
Kim, Min Young
Jo, Eunbi
Uversky, Vladimir N.
Kim, Chul Geun
author_facet Son, Seung Han
Kim, Min Young
Jo, Eunbi
Uversky, Vladimir N.
Kim, Chul Geun
author_sort Son, Seung Han
collection PubMed
description CP2c, also known as TFCP2, α-CP2, LSF, and LBP-1c, is a prototypic member of the transcription factor (TF) CP2 subfamily involved in diverse ubiquitous and tissue/stage-specific cellular processes and in human malignancies including cancer. Despite its importance, many fundamental regulatory mechanisms of CP2c are still unclear. Here, we uncover unprecedented structural and functional aspects of CP2c using DSP crosslinking and Western blot in addition to conventional methods. We found that a monomeric form of a CP2c homotetramer (tCP2c; [C4]) binds to the known CP2c-binding DNA motif (CNRG-N(5~6)-CNRG), whereas a dimeric form of a CP2c, CP2b, and PIAS1 heterohexamer ([C2B2P2](2)) binds to the three consecutive CP2c half-sites or two staggered CP2c binding motifs, where the [C4] exerts a pioneering function for recruiting the [C2B2P2](2) to the target. All CP2c exists as a [C4], or as a [C2B2P2](2) or [C2B2P2](4) in the nucleus. Importantly, one additional cytosolic heterotetrameric CP2c and CP2a complex, ([C2A2]), exerts some homeostatic regulation of the nuclear complexes. These data indicate that these findings are essential for the transcriptional regulation of CP2c in cells within relevant timescales, providing clues not only for the transcriptional regulation mechanism by CP2c but also for future therapeutics targeting CP2c function.
format Online
Article
Text
id pubmed-9223585
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92235852022-06-24 Structural and Functional Insights into CP2c Transcription Factor Complexes Son, Seung Han Kim, Min Young Jo, Eunbi Uversky, Vladimir N. Kim, Chul Geun Int J Mol Sci Article CP2c, also known as TFCP2, α-CP2, LSF, and LBP-1c, is a prototypic member of the transcription factor (TF) CP2 subfamily involved in diverse ubiquitous and tissue/stage-specific cellular processes and in human malignancies including cancer. Despite its importance, many fundamental regulatory mechanisms of CP2c are still unclear. Here, we uncover unprecedented structural and functional aspects of CP2c using DSP crosslinking and Western blot in addition to conventional methods. We found that a monomeric form of a CP2c homotetramer (tCP2c; [C4]) binds to the known CP2c-binding DNA motif (CNRG-N(5~6)-CNRG), whereas a dimeric form of a CP2c, CP2b, and PIAS1 heterohexamer ([C2B2P2](2)) binds to the three consecutive CP2c half-sites or two staggered CP2c binding motifs, where the [C4] exerts a pioneering function for recruiting the [C2B2P2](2) to the target. All CP2c exists as a [C4], or as a [C2B2P2](2) or [C2B2P2](4) in the nucleus. Importantly, one additional cytosolic heterotetrameric CP2c and CP2a complex, ([C2A2]), exerts some homeostatic regulation of the nuclear complexes. These data indicate that these findings are essential for the transcriptional regulation of CP2c in cells within relevant timescales, providing clues not only for the transcriptional regulation mechanism by CP2c but also for future therapeutics targeting CP2c function. MDPI 2022-06-07 /pmc/articles/PMC9223585/ /pubmed/35742810 http://dx.doi.org/10.3390/ijms23126369 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Son, Seung Han
Kim, Min Young
Jo, Eunbi
Uversky, Vladimir N.
Kim, Chul Geun
Structural and Functional Insights into CP2c Transcription Factor Complexes
title Structural and Functional Insights into CP2c Transcription Factor Complexes
title_full Structural and Functional Insights into CP2c Transcription Factor Complexes
title_fullStr Structural and Functional Insights into CP2c Transcription Factor Complexes
title_full_unstemmed Structural and Functional Insights into CP2c Transcription Factor Complexes
title_short Structural and Functional Insights into CP2c Transcription Factor Complexes
title_sort structural and functional insights into cp2c transcription factor complexes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223585/
https://www.ncbi.nlm.nih.gov/pubmed/35742810
http://dx.doi.org/10.3390/ijms23126369
work_keys_str_mv AT sonseunghan structuralandfunctionalinsightsintocp2ctranscriptionfactorcomplexes
AT kimminyoung structuralandfunctionalinsightsintocp2ctranscriptionfactorcomplexes
AT joeunbi structuralandfunctionalinsightsintocp2ctranscriptionfactorcomplexes
AT uverskyvladimirn structuralandfunctionalinsightsintocp2ctranscriptionfactorcomplexes
AT kimchulgeun structuralandfunctionalinsightsintocp2ctranscriptionfactorcomplexes